C

Clinical Research Institute, Inc. | Minneapolis, MN

Research site
(Unclaimed)
Location
825 Nicollet Mall, Suite 1135, Minneapolis, Minnesota, United States of America
Site insights

Top conditions

Migraine Disorders (12 trials)

Dermatitis (3 trials)

Asthma (3 trials)

Eczema (3 trials)

Atopic Dermatitis (3 trials)

Top treatments

Rimegepant
Atogepant
PF-04965842
BMS-927711
Symbicort®
Zavegepant
Zolmitriptan
Fluticasone Propionate
GB001
Azelastine Hydrochloride

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 23
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults

The main objective of Part A of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults and the mai...

Active, not recruiting
Epstein-Barr Virus Infection
Biological: mRNA-1189
Biological: Placebo

The purpose of this study is to evaluate the safety and immunogenicity in parallel of heptavalent mRNA-1975 and monovalent mRNA-1982 against Lyme dis...

Active, not recruiting
Lyme Disease
Biological: mRNA-1975
Biological: Placebo

VLA15-221 is a Phase 2 study, which will be conducted in two parts: Main Study Phase (Part A) and Booster Phase (Part B). The study will compare the...

Active, not recruiting
Lyme Borreliosis
Biological: Placebo
Biological: VLA15
Locations recently updated

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial sponsors

Pfizer logo

Pfizer (10 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems